Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa.

作者: Nicholas Musinguzi , Collins D Muganzi , II Yap Boum , Allan Ronald , Mark A Marzinke

DOI: 10.1097/QAD.0000000000001024

关键词:

摘要: Background Preexposure prophylaxis (PrEP) efficacy is highly dependent on adherence. Yet, it unclear which adherence measures perform best for PrEP. Methods We compared three types of self-reported questions (rating ability to adhere, frequency doses taken, percentage taken) and forms objective measurement [unannounced pill counts (UPC), electronic monitoring, plasma tenofovir levels] using data from an ancillary study within a clinical trial PrEP among East African serodiscordant couples (Partners Study). Monthly were assessed the first 6 months follow-up. Results One thousand, one hundred forty-seven participants contributed 6048 person-months this analysis. Median was high: rating (90%), (93%), (97%); UPC (99%); monitoring (97%). Prevalence steady-state daily dosing (SSDD; ≥40 ng/ml) 74% in random subset samples obtained 365 participants. Discrimination SSDD versus less than levels poor [area under receiver-operating curve (AROC) 0.54], (AROC 0.52), 0.56) 0.58), but moderate 0.70). Correlation measures, (0.61-0.66), low these with (0.32-0.36) (0.22-0.28). Conclusion Electronic only measure meaningful discriminate between levels. subjective poor. Future research should explore novel approaches as moves into demonstration projects programmatic implementation.

参考文章(36)
Ariane van der Straten, Lut Van Damme, Jessica E. Haberer, David R. Bangsberg, Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention AIDS. ,vol. 26, pp. F13- F19 ,(2012) , 10.1097/QAD.0B013E3283522272
Beumer Jh, Maes Ra, Bosman Ij, Hair as a biological specimen for therapeutic drug monitoring. International Journal of Clinical Practice. ,vol. 55, pp. 353- 357 ,(2001)
David R. Bangsberg, Frederick M. Hecht, Edwin D. Charlebois, Margaret Chesney, Andrew Moss, Comparing Objective Measures of Adherence to HIV Antiretroviral Therapy: Electronic Medication Monitors and Unannounced Pill Counts Aids and Behavior. ,vol. 5, pp. 275- 281 ,(2001) , 10.1023/A:1011396711486
Craig W. Hendrix, Adriana Andrade, Namandjé N. Bumpus, Angela D. Kashuba, Mark A. Marzinke, Ayana Moore, Peter L. Anderson, Lane R. Bushman, Edward J. Fuchs, Ilene Wiggins, Christine Radebaugh, Heather A. Prince, Rahul P. Bakshi, Ruili Wang, Paul Richardson, Eugenie Shieh, Laura McKinstry, Xin Li, Deborah Donnell, Vanessa Elharrar, Kenneth H. Mayer, Kristine B. Patterson, Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066) AIDS Research and Human Retroviruses. ,vol. 32, pp. 32- 43 ,(2016) , 10.1089/AID.2015.0182
Ira B. Wilson, Floyd J. Fowler, Carol A. Cosenza, Joanne Michaud, Judy Bentkover, Aadia Rana, Laura Kogelman, William H. Rogers, Cognitive and Field Testing of a New Set of Medication Adherence Self-Report Items for HIV Care Aids and Behavior. ,vol. 18, pp. 2349- 2358 ,(2014) , 10.1007/S10461-013-0610-1
Ira B. Wilson, Amanda E. Carter, Karina M. Berg, Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Current Hiv\/aids Reports. ,vol. 6, pp. 177- 186 ,(2009) , 10.1007/S11904-009-0024-X
David R. Bangsberg, Frederick M. Hecht, Edwin D. Charlebois, Andrew R. Zolopa, Mark Holodniy, Lewis Sheiner, Joshua D. Bamberger, Margaret A. Chesney, Andrew Moss, Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. ,vol. 14, pp. 357- 366 ,(2000) , 10.1097/00002030-200003100-00008
Betsy J Feldman, Rob J Fredericksen, Paul K Crane, Stephen A Safren, Michael J Mugavero, James H Willig, Jane M Simoni, IB Wilson, MS Saag, Mari M Kitahata, Heidi M Crane, None, Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. Aids and Behavior. ,vol. 17, pp. 307- 318 ,(2013) , 10.1007/S10461-012-0326-7
Poloko M. Kebaabetswe, Michael J. Stirratt, Eleanor McLellan-Lemal, Faith L. Henderson, Simone C. Gray, Charles E. Rose, Tiffany Williams, Lynn A. Paxton, Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitibine as Pre-exposure Prophylaxis (Prep) Clinical Trial, Botswana, 2007-2010. Aids and Behavior. ,vol. 19, pp. 758- 769 ,(2015) , 10.1007/S10461-014-0891-Z
Albert Y. Liu, Qiyun Yang, Yong Huang, Peter Bacchetti, Peter L. Anderson, Chengshi Jin, Kathy Goggin, Kristefer Stojanovski, Robert Grant, Susan P. Buchbinder, Ruth M. Greenblatt, Monica Gandhi, Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP) PLoS ONE. ,vol. 9, pp. e83736- ,(2014) , 10.1371/JOURNAL.PONE.0083736